Company Profiles

driven by the PitchBook Platform

Atlas Genetics

Description

Developer of a novel molecular diagnostic system is designed for decentralised laboratory, point-of-care and other near-patient settings. The company's molecular diagnostic system is based on a patent- protected electrochemical sensor is used for the ultra-rapid diagnosis of a broad range of infectious diseases such as chlamydia, gonorrhoea, meningitis and MRSA enabling physicians to get accurate diagnostic reports.

2005

Founded

PRIVATE

Status

11-50

Employees

Series D

Latest Deal Type

$35M

Latest Deal Amount

$91.5M

Total Amount Raised

Description

Developer of a novel molecular diagnostic system is designed for decentralised laboratory, point-of-care and other near-patient settings. The company's molecular diagnostic system is based on a patent- protected electrochemical sensor is used for the ultra-rapid diagnosis of a broad range of infectious diseases such as chlamydia, gonorrhoea, meningitis and MRSA enabling physicians to get accurate diagnostic reports.

Website:

www.atlasgenetics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Drug Discovery

Primary Office

Derby Court, Epsom Square White Horse Business Park, Wiltshire Trowbridge BA14 0XGEngland +44 (0)12 2571 7930
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Atlas Genetics's full profile, request a free trial.

Atlas Genetics Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Atlas Genetics Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Atlas Genetics Investors (16)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BB Biotech VenturesVenture CapitalMinority000 0000000 0000
Braveheart Investment GroupVenture CapitalMinority000 0000000 0000
Consort MedicalCorporationMinority000 0000000 0000
GEIF VenturesVenture CapitalMinority000 0000000 0000
Innovate UKAccelerator/Incubator000 0000000 0000
BB Biotech Ventures Venture Capital
Braveheart Investment Group Venture Capital
Consort Medical Corporation
GEIF Ventures Venture Capital
Innovate UK Accelerator/Incubator

Atlas Genetics Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Ben ArlettChief Technology Officer
John Clarkson Ph.DChief Executive Officer & Board Member
Lee Johnston Jr.Chief Financial Officer
Karen YatesDirector, Finance & Board Member
David WhitakerDirector, Operations
Ben Arlett Chief Technology Officer
John Clarkson Ph.D Chief Executive Officer & Board Member
Lee Johnston Jr. Chief Financial Officer
Karen Yates Director, Finance & Board Member
David Whitaker Director, Operations

Atlas Genetics Board Members (13)

NameRepresentingRoleSinceContact
Info
Christopher PriceAtlas GeneticsBoard Member000 0000
Clive DavisSelfBoard Observer000 0000
Florent GrosNovartis Venture FundManaging Director000 0000
Joachim Rothe Ph.DLife Sciences PartnersManaging Partner & Co-Owner000 0000
John Clarkson Ph.DAtlas GeneticsChief Executive Officer & Board Member000 0000
Christopher Price Board Member Atlas Genetics
Clive Davis Board Observer Self
Florent Gros Managing Director Novartis Venture Fund
Joachim Rothe Ph.D Managing Partner & Co-Owner Life Sciences Partners
John Clarkson Ph.D Chief Executive Officer & Board Member Atlas Genetics
Request full access to PitchBook